About NEXTBIOMEDICAL
NEXTBIOMEDICAL is a company based in Incheon (South Korea) founded in 2014.. NEXTBIOMEDICAL operates in a competitive market with competitors including Insulet, Lyra Therapeutics, TriSalus Life Sciences, Credence MedSystems and MiNA Therapeutics, among others.
- Headquarter Incheon, South Korea
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Nextbiomedical Co., Ltd.
-
Annual Revenue
$6.47 M (USD)95.46as on Dec 31, 2024
-
Net Profit
$1.94 M (USD)0as on Dec 31, 2024
-
EBITDA
$-2.09 M (USD)35.23as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of NEXTBIOMEDICAL
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by NEXTBIOMEDICAL
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NEXTBIOMEDICAL
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nextbiomedical Comparisons
Competitors of NEXTBIOMEDICAL
NEXTBIOMEDICAL operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insulet, Lyra Therapeutics, TriSalus Life Sciences, Credence MedSystems and MiNA Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Wearable insulin infusion systems are developed for diabetes patients.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for ENT diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of drug delivery devices to treat cancers
|
|
| domain | founded_year | HQ Location |
Developer of smart devices for drug delivery
|
|
| domain | founded_year | HQ Location |
Small activating RNA therapeutics are developed to restore gene function.
|
|
| domain | founded_year | HQ Location |
Injectables and NCEs for cancer and chronic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about NEXTBIOMEDICAL
When was NEXTBIOMEDICAL founded?
NEXTBIOMEDICAL was founded in 2014.
Where is NEXTBIOMEDICAL located?
NEXTBIOMEDICAL is headquartered in Incheon, South Korea.
Who is the current CEO of NEXTBIOMEDICAL?
Lee Don Haeng is the current CEO of NEXTBIOMEDICAL.
What is the annual revenue of NEXTBIOMEDICAL?
Annual revenue of NEXTBIOMEDICAL is $6.47M as on Dec 31, 2024.
What does NEXTBIOMEDICAL do?
NextBiomedical manufactures drugs and delivery systems for wound dressing for gastrointestinal bleeding. The product Nexpowder designed for endoscopic hemostasis and ulcer protection after gastrointestinal bleeding or endoscopic procedures. Nexsphere is a polymeric microparticle that is inserted into blood vessels, performs the hemostatic effect and blocks the nutritional sources of abnormal tissues or induce tumor necrosis which helps in detection for cancer. NEXENT is a targeting therapeutic material.
Who are the top competitors of NEXTBIOMEDICAL?
NEXTBIOMEDICAL's top competitors include Insulet, MiNA Therapeutics and Lyra Therapeutics.